[A clinical trial of pefloxacin (Abaktal) in the treatment of acute pyelonephritis].
The therapeutic effect of Pefloxacin in the treatment of acute pyelonephritis was examined in a randomized clinical trial. The patients in the control group have been treated by gentamycin. With a success rate of 80% in the treatment of acute pyelonephritis caused by various bacteria (E. coli, Pseudomonas, Klebsiella, Staphylococcus aureus, Proteus mirab.), a side frequency of side effects and a good compliance Pefloxacin is recommended as an effective antimicrobiell drug.
Klinik für Urologie, Medizinischen Akademie Carl Gustav Carus Dresden.
J
J
Gorski
J
J
Wehnert
D
D
Lange
H
H
Koch
G
G
Wichmann
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D015366:Pefloxacin / Q000627:therapeutic use*; D011704:Pyelonephritis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
D005839:Gentamicins; D015366:Pefloxacin
Klinische Studie von Pefloxacin (ABAKTAL) in der Behandlung der akuten Pyelonephritis.